Indications for the endoscopic lumbar interbody fusion
EndoLIF® Implants stabilize the intervertebral disc space with the aim to support a bony fusion of vertebral bodies in the non-cervical spine. The cages can be implanted minimally invasively via a posterior or posterolateral access. EndoLIF® Implants always have to be combined with a dorsal fixation, such as the percutaneous screw-rod-system Percusys® by joimax®.
The fusion of vertebral bodies is a final step, nevertheless, this treatment for spinal stabilization can be necessary for the following indication:
- Degenerative disc disease
- Mechanical instability
- Spondylolisthesis grade I or II (Meyerding)
- Secondary instabilities following surgical procedures on the lumbar spine
The EndoLIF® Cages are indicated for intervertebral body fusion procedures in skeletally mature patients with degenerative disc disease (DDD) of the lumbar spine at one or two contiguous levels from L2-S1. Degenerative disc disease is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. These patients may also have up to Grade I spondylolisthesis at the involved level(s). These patients may have had previous non-fusion spinal surgery at the involved spinal level(s). EndoLIF® Cages are to be used with autogenous bone and implanted via a posterior or posterolateral approach. The EndoLIF® Cages are to be used with supplemental FDA cleared fixation. Patients should have at least six months of non-operative treatment prior to treatment with an EndoLIF® Cage.